Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter Veterinary Remove Veterinary filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Summaries of opinion Remove Summaries of opinion filter Maximum residue limits Remove Maximum residue limits filter Referrals Remove Referrals filter

Product number

Date of opinion

From:

To:

Referral name

Referral status

European Commission final decision Remove European Commission final decision filter Opinion provided by Committee for Medicinal Products for Human Use Remove Opinion provided by Committee for Medicinal Products for Human Use filter CMDh final position (18) Apply CMDh final position filter Under evaluation (2) Apply Under evaluation filter

Referral safety status

Yes (23) Apply Yes filter

Referral type

Article 20 procedures (24) Apply Article 20 procedures filter Article 31 referrals (21) Apply Article 31 referrals filter Article 29(4) referrals (14) Apply Article 29(4) referrals filter Article 35 (6) Apply Article 35 filter Article 107i procedures (6) Apply Article 107i procedures filter Article 30 referrals (2) Apply Article 30 referrals filter Article 34 (2) Apply Article 34 filter Article 13 referrals (1) Apply Article 13 referrals filter Article 33 (1) Apply Article 33 filter

Referral reference number

Referral decision making model

PRAC-CAT-CHMP-EC (1) Apply PRAC-CAT-CHMP-EC filter PRAC-CHMP-EC (19) Apply PRAC-CHMP-EC filter PRAC-CMDh (18) Apply PRAC-CMDh filter

Referral authorisation model

Centrally authorised product(s) Remove Centrally authorised product(s) filter Nationally authorised product(s) Remove Nationally authorised product(s) filter Centrally and nationally authorised products (mixed) (14) Apply Centrally and nationally authorised products (mixed) filter

Referral PRAC recommendation

No further action (1) Apply No further action filter Revocation (2) Apply Revocation filter Risk minimisation measures (23) Apply Risk minimisation measures filter Suspension (5) Apply Suspension filter Variation (7) Apply Variation filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Decision date

From:

To:

Medicine type

Accelerated assessment (3) Apply Accelerated assessment filter Additional monitoring (12) Apply Additional monitoring filter Conditional approval (3) Apply Conditional approval filter Orphan medicine (1) Apply Orphan medicine filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

77 results

Remove all filtersRemove all filters

Medicine Maximum residue limits Remove Maximum residue limits filter Referrals Remove Referrals filter Summaries of opinion Remove Summaries of opinion filter

Categories Veterinary Remove Veterinary filter Human Remove Human filter

Referral authorisation model Nationally authorised product(s) Remove Nationally authorised product(s) filter Centrally authorised product(s) Remove Centrally authorised product(s) filter

Referral status European Commission final decision Remove European Commission final decision filter Opinion provided by Committee for Medicinal Products for Human Use Remove Opinion provided by Committee for Medicinal Products for Human Use filter

Sort by

List item

Referral: Ronaxan and its associated names

Doxycycline, Article 34
Status: European Commission final decision, opinion/position date: 17/06/2021, EC decision date: 30/08/2021, Last updated: 27/09/2021
List item

Referral: Veterinary medicinal products containing toltrazuril to be administered orally to chickens

toltrazuril, Article 35
Status: European Commission final decision, opinion/position date: 14/07/2022, EC decision date: 09/11/2022, Last updated: 14/12/2022

77 results

Referral: Ronaxan and its associated names

Referral: Veterinary medicinal products containing toltrazuril to be administered orally to chickens